Why outdated methods are holding pharma back—and how digital transformation changes the game.
It’s been more than 25 years since the FDA introduced 21 CFR Part 11, yet many pharmaceutical manufacturers and CDMOs are still stuck with paper-based systems, spreadsheets, and legacy tools. These outdated methods may feel “good enough,” but in reality they increase compliance risk, create inefficiencies, and slow innovation.
Our whitepaper, From Paper to Performance, traces the evolution of maintenance management in pharma—from the early days of manual logs to today’s AI-enabled, cloud-based platforms. You’ll see why so many organizations have hesitated to modernize, the measurable performance gains achieved by those who have, and what steps your organization can take to make the leap.
Download your copy today to learn how moving from paper to performance can cut audit prep time, reduce downtime, improve data integrity, and drive continuous improvement across your operations.